Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07650669 · ClinicalTrials.gov registry record

Wearable Technology in Heart Failure Patients

A clinical trial, sponsored by The Cleveland Clinic.

Recruiting
Registry status
500
Enrollment target

NCT07650669: Recruiting study, sponsored by The Cleveland Clinic.

NCT07650669 is a clinical trial that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07650669 is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
500 participants
Enrollment target

Study Summary

The primary objective is to establish a Cleveland Clinic-led registry designed to integrate continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University (CWRU)-based platform, with clinical data from patients' individual Electronic Health Record (EHR). This proposal is for understanding the use of personal wearable devices (such as: Fitbit, and Apple Watch) to gather physiological data (such as: heart-rate, steps taken, sleep cycles, and calories expended) and correlate those data with self-reported health status. The research team intends to collect all of the data generated by the participant's personal wearable devices and to perform an integrated analysis of the physiological data generated by the wearable devices. The investigators specifically aim to uncover patterns from the data that they can evolve models from. The investigators' goal is to better predict and diagnose the adverse effects associated with daily lifestyle, including cardiovascular risk, musculoskeletal, metabolic risks, stress, and sleep disturbances. These data may be used to better understand the daily habits and lifestyle choices to possibly predict a person's health and disease risk to provide a more comprehensive diagnosis with early recognition and prevention. As wearable devices become more accurate and cheaper to purchase for the general public, integrative analysis of wearable data from multiple devices may lead to models that can be used by clinicians and basic scientists to make inferences about the daily lifestyle and its effects on health and disease.

Primary Outcome

To establish a Cleveland Clinic-led registry that integrates continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University-based platform, with comprehensive clinical and laboratory data from the Cleveland Clinic EHR.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-06
Est. Completion 2040-06
The Cleveland Clinic

688 total trials

What NCT07650669 shows while recruiting

NCT07650669 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT07650669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07650669 about?

NCT07650669 is a clinical study titled "Wearable Technology in Heart Failure Patients". The primary objective is to establish a Cleveland Clinic-led registry designed to integrate continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University (CWRU)-based platform, with clinical data from patients' individual Electronic Health ...

What is the current status of trial NCT07650669?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-06. Estimated completion is 2040-06.

Who is sponsoring clinical trial NCT07650669?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07650669, the US trial registry maintained by the National Library of Medicine. NCT07650669 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.